Cargando…

Correction to: CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway

Detalles Bibliográficos
Autores principales: Gong, Xuelian, Li, Wei, Dong, Lin, Qu, Fangfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369128/
https://www.ncbi.nlm.nih.gov/pubmed/32666371
http://dx.doi.org/10.1007/s10735-020-09894-5
_version_ 1783560732633202688
author Gong, Xuelian
Li, Wei
Dong, Lin
Qu, Fangfei
author_facet Gong, Xuelian
Li, Wei
Dong, Lin
Qu, Fangfei
author_sort Gong, Xuelian
collection PubMed
description
format Online
Article
Text
id pubmed-7369128
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-73691282020-07-22 Correction to: CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway Gong, Xuelian Li, Wei Dong, Lin Qu, Fangfei J Mol Histol Correction Springer Netherlands 2020-07-14 2020 /pmc/articles/PMC7369128/ /pubmed/32666371 http://dx.doi.org/10.1007/s10735-020-09894-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correction
Gong, Xuelian
Li, Wei
Dong, Lin
Qu, Fangfei
Correction to: CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway
title Correction to: CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway
title_full Correction to: CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway
title_fullStr Correction to: CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway
title_full_unstemmed Correction to: CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway
title_short Correction to: CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway
title_sort correction to: circubap2 promotes sema6d expression to enhance the cisplatin resistance in osteosarcoma through sponging mir-506-3p by activating wnt/β-catenin signaling pathway
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369128/
https://www.ncbi.nlm.nih.gov/pubmed/32666371
http://dx.doi.org/10.1007/s10735-020-09894-5
work_keys_str_mv AT gongxuelian correctiontocircubap2promotessema6dexpressiontoenhancethecisplatinresistanceinosteosarcomathroughspongingmir5063pbyactivatingwntbcateninsignalingpathway
AT liwei correctiontocircubap2promotessema6dexpressiontoenhancethecisplatinresistanceinosteosarcomathroughspongingmir5063pbyactivatingwntbcateninsignalingpathway
AT donglin correctiontocircubap2promotessema6dexpressiontoenhancethecisplatinresistanceinosteosarcomathroughspongingmir5063pbyactivatingwntbcateninsignalingpathway
AT qufangfei correctiontocircubap2promotessema6dexpressiontoenhancethecisplatinresistanceinosteosarcomathroughspongingmir5063pbyactivatingwntbcateninsignalingpathway